en

PRODUCT DETAIL

Lojuxta 60 mg tvrdé kapsuly

Code 0438C
MA number EU/1/13/851/006
Product Form: cps dur 28x60 mg (fľ.HDPE)
MA Status: Ev - Valid centralised marketing authorisation under exceptional circumstances
Type of procedure: EU
Therapeutic Class: 31 - HYPOLIPIDAEMICA
ATC:
C CARDIOVASCULAR SYSTEM
C10 Lipid modifying agents
C10A Lipid modifying agents, plain
C10AX Other lipid modifying agents
C10AX12 Lomitapide
Shelf life: 36
Container: bottle PE
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 18.02.2016
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 05.06.2023
eu-flag.png sk-flag.png